Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

doi:10.1084/jem.161.5.984

This Article

	Full Text (PDF, 870K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Beutler, B.
	Articles by Cerami, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Beutler, B.
	Articles by Cerami, A.


Social Bookmarking

	What's this?

ARTICLES

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

B Beutler, J Mahoney, N Le Trang, P Pekala and A Cerami

Previous studies have indicated that endotoxin and other bacterial and protozoal products can stimulate macrophages to produce a factor that can suppress the activity of the enzyme lipoprotein lipase (LPL), in vivo and in vitro. In the present report we describe the purification of this factor, cachectin, to apparent homogeneity from the conditioned medium of endotoxin-stimulated RAW 264.7 cells. The isolated protein has an isoelectric point of 4.7 and a subunit molecular weight of 17,000. Although cachectin's isoelectric point and molecular weight are similar to those described for interleukin 1, pure cachectin has no leukocyte-activating factor (LAF) activity. Cachectin at a concentration of 10(-11) M has the ability to suppress the LPL activity of the 3T3-L1 adipocyte cell line by 80%. Binding studies using radio- labeled cachectin and 3T3-L1 adipocytes and C2 myotubules revealed approximately 10(4) high-affinity receptors per cell on both cell types (Ka, 3 X 10(9]. Cachectin receptors were also present on liver membranes but were absent on erythrocytes and lymphocytes. The isolation of cachectin and characterization of its receptor should facilitate further investigations into the role of cachectin and other macrophage mediators in the metabolic derangements that occur during infection and cachexia.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Beutler, B. A. (2009). TLRs and innate immunity. Blood 113: 1399-1407 [Abstract] [Full Text]
Frostegard, J (2008). Systemic lupus erythematosus and cardiovascular disease. Lupus 17: 364-367 [Abstract]
Atsumi, T., Cho, Y.-R., Leng, L., McDonald, C., Yu, T., Danton, C., Hong, E.-G., Mitchell, R. A., Metz, C., Niwa, H., Takeuchi, J., Onodera, S., Umino, T., Yoshioka, N., Koike, T., Kim, J. K., Bucala, R. (2007). The Proinflammatory Cytokine Macrophage Migration Inhibitory Factor Regulates Glucose Metabolism during Systemic Inflammation. J. Immunol. 179: 5399-5406 [Abstract] [Full Text]
Bashyam, H. (2007). Uncovering the dark side of TNF. JEM 204: 2013-2013 [Abstract] [Full Text]
Ardoin, S., Sandborg, C., Schanberg, L. (2007). Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus 16: 618-626 [Abstract]
Miller, R. R., Cappola, A. R., Shardell, M. D., Hawkes, W. G., Yu-Yahiro, J. A., Hebel, J. R., Magaziner, J. (2006). Persistent changes in interleukin-6 and lower extremity function following hip fracture.. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61: 1053-1058 [Abstract] [Full Text]
Kim, J., Ha, Y., Chae, C. (2006). Potentiation of Porcine Circovirus 2-induced Postweaning Multisystemic Wasting Syndrome by Porcine Parvovirus Is Associated with Excessive Production of Tumor Necrosis Factor-{alpha}.. Vet Pathol 43: 718-725 [Abstract] [Full Text]
Siddiqui, R., Pandya, D., Harvey, K., Zaloga, G. P. (2006). Nutrition Modulation of Cachexia/Proteolysis. Nutr Clin Pract 21: 155-167 [Abstract] [Full Text]
Delano, M. J., Moldawer, L. L. (2006). The Origins of Cachexia in Acute and Chronic Inflammatory Diseases. Nutr Clin Pract 21: 68-81 [Abstract] [Full Text]
Honma, K., Udono, H., Kohno, T., Yamamoto, K., Ogawa, A., Takemori, T., Kumatori, A., Suzuki, S., Matsuyama, T., Yui, K. (2005). Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. Proc. Natl. Acad. Sci. USA 102: 16001-16006 [Abstract] [Full Text]
Frostegard, J. (2005). Atherosclerosis in Patients With Autoimmune Disorders. Arterioscler. Thromb. Vasc. Bio. 25: 1776-1785 [Abstract] [Full Text]
Ferraccioli, G F, Gremese, E (2004). Autoantibodies and thrombophilia in RA: TNF{alpha} and TNF{alpha} blockers. Ann Rheum Dis 63: 613-615 [Full Text]
Wu, G., Brouckaert, P., Olivecrona, T. (2004). Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-{alpha} is involved. Am. J. Physiol. Endocrinol. Metab. 286: E711-E717 [Abstract] [Full Text]
Iontcheva, I., Amar, S., Zawawi, K. H., Kantarci, A., Van Dyke, T. E. (2004). Role for Moesin in Lipopolysaccharide-Stimulated Signal Transduction. Infect. Immun. 72: 2312-2320 [Abstract] [Full Text]
Philipp, J., Dienst, A., Unruh, M., Wagener, A., Grunow, A., Engert, A., Fries, J. W.U., Gottstein, C. (2003). Soluble Tissue Factor Induces Coagulation on Tumor Endothelial Cells In Vivo if Coadministered With Low-Dose Lipopolysaccharides. Arterioscler. Thromb. Vasc. Bio. 23: 905-910 [Abstract] [Full Text]
Rubin, H. (2003). Cancer cachexia: Its correlations and causes. Proc. Natl. Acad. Sci. USA 100: 5384-5389 [Abstract] [Full Text]
Hansson, G. K. (2001). Immune Mechanisms in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 21: 1876-1890 [Abstract] [Full Text]
GREIWE, J. S., CHENG, B., RUBIN, D. C., YARASHESKI, K. E., SEMENKOVICH, C. F. (2001). Resistance exercise decreases skeletal muscle tumor necrosis factor {alpha} in frail elderly humans. FASEB J. 15: 475-482 [Abstract] [Full Text]
Zhang, Y., Pilon, G., Marette, A., Baracos, V. E. (2000). Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279: E196-E205 [Abstract] [Full Text]
Feldman, A. M., Combes, A., Wagner, D., Kadakomi, T., Kubota, T., You Li, Y., McTiernan, C. (2000). The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35: 537-544 [Abstract] [Full Text]
Fox, D. A. (2000). Cytokine Blockade as a New Strategy to Treat Rheumatoid Arthritis: Inhibition of Tumor Necrosis Factor. Arch Intern Med 160: 437-444 [Abstract] [Full Text]
Qi, C., Pekala, P. H. (2000). Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance in Adipocytes. Exp. Biol. Med. 223: 128-135 [Abstract] [Full Text]
Botella, L. M., Puig-Kroger, A., Almendro, N., Sanchez-Elsner, T., Munoz, E., Corbi, A., Bernabeu, C. (2000). Identification of a Functional NF-{kappa}B Site in the Platelet Endothelial Cell Adhesion Molecule-1 Promoter. J. Immunol. 164: 1372-1378 [Abstract] [Full Text]
Swantek, J. L., Christerson, L., Cobb, M. H. (1999). Lipopolysaccharide-induced Tumor Necrosis Factor-{alpha} Promoter Activity Is Inhibitor of Nuclear Factor-{kappa}B Kinase-dependent. J. Biol. Chem. 274: 11667-11671 [Abstract] [Full Text]
Li, Y.-p., Schwartz, R. J., Waddell, I. D., Holloway, B. R., Reid, M. B. (1998). Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-{kappa}B activation in response to tumor necrosis factor {alpha}. FASEB J. 12: 871-880 [Abstract] [Full Text]
Chiu, H-H, Lee, C-Y, Lee, P-I, Lin, K-H, Huang, L-M (1998). Mononucleosis syndrome and coincidental human herpesvirus-7 and Epstein-Barr virus infection. Arch. Dis. Child. 78: 479-480 [Abstract] [Full Text]
Meldrum, D. R. (1998). Tumor necrosis factor in the heart. Am. J. Physiol. Regul. Integr. Comp. Physiol. 274: R577-R595 [Abstract] [Full Text]
Magez, S., Stijlemans, B., Radwanska, M., Pays, E., Ferguson, M. A. J., De Baetselier, P. (1998). The Glycosyl-Inositol-Phosphate and Dimyristoylglycerol Moieties of the Glycosylphosphatidylinositol Anchor of the Trypanosome Variant-Specific Surface Glycoprotein Are Distinct Macrophage-Activating Factors. J. Immunol. 160: 1949-1956 [Abstract] [Full Text]
Bursten, S. L., Federighi, D., Wald, J., Meengs, B., Spickler, W., Nudelman, E. (1998). Lisofylline Causes Rapid and Prolonged Suppression of Serum Levels of Free Fatty Acids. J. Pharmacol. Exp. Ther. 284: 337-345 [Abstract] [Full Text]
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., Feldman, A. M. (1997). Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-{alpha}. Circ. Res. 81: 627-635 [Abstract] [Full Text]
Borba, E., Bonfa, E. (1997). Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 6: 533-539 [Abstract]
Meakins, J. L. (1996). Surgical Infection in Art. Arch Surg 131: 1289-1295 [Abstract]
Bazzoni, F., Beutler, B. (1996). The Tumor Necrosis Factor Ligand and Receptor Families. NEJM 334: 1717-1725 [Full Text]
Pass, H. I., Mew, D. J. Y., Kranda, K. C., Temeck, B. K., Donington, J. S., Rosenberg, S. A. (1996). Isolated Lung Perfusion With Tumor Necrosis Factor for Pulmonary Metastases. Ann. Thorac. Surg. 61: 1609-1617 [Abstract] [Full Text]
Arroyo, C. M, Von Tersch, R. L, Broomfield, C. A (1995). Activation of alpha-human tumour necrosis factor (TNF-{alpha}) by human monocytes (THP-1) exposed to 2-chloroethyl ethyl sulphide (H-MG). Hum Exp Toxicol 14: 547-553 [Abstract]
Gollaher, C. J., Fechner, K., Karlstad, M., Babayan, V. K., Bistrian, B. R. (1993). The Effect of Increasing Levels of Fish Oil-Containing Structured Triglycerides on Protein Metabolism in Parenterally Fed Rats Stressed by Burn Plus Endotoxin. JPEN J Parenter Enteral Nutr 17: 247-253 [Abstract]
Mcnamara, M. J., Alexander, H. R., Norton, J. A. (1992). Cytokines and Their Role in the Pathophysiology of Cancer Cachexia. JPEN J Parenter Enteral Nutr 16: 50S-55S [Abstract]
Maliakkal, R. J., Blackburn, G. L., Willcutts, H. D., Williams, M., Levin, R., Willcutts, H. D. JR, Elashoff, R. (1992). Optimal Design of Clinical Outcome Studies in Nutrition and Cancer: Future Directions. JPEN J Parenter Enteral Nutr 16: 112S-116S [Abstract]
Rossi-Fanelli, F., Cascino, A., Muscaritoli, M. (1991). Review: Abnormal Substrate Metabolism and Nutritional Strategies in Cancer Management. JPEN J Parenter Enteral Nutr 15: 680-683 [Abstract]
Baker, C. C., Tracy Niven-Fairchild, A., Yamada, A., Caragnano, C. L., Kupper, T. S. (1991). Macrophage Antigen Presentation and Interleukin 1 Production After Cecal Ligation and Puncture in C3H/HeN and C3H/HeJ Mice. Arch Surg 126: 253-258 [Abstract]
Mayoral, J. L., Schweich, CyrilJ., Dunn, D. L. (1990). Decreased Tumor Necrosis Factor Production During the Initial Stages of Infection Correlates With Survival During Murine Gram-negative Sepsis. Arch Surg 125: 24-28 [Abstract]
Schirmer, W. J., Schirmer, J. M., Fry, D. E. (1989). Recombinant Human Tumor Necrosis Factor Produces Hemodynamic Changes Characteristic of Sepsis and Endotoxemia. Arch Surg 124: 445-448 [Abstract]
Stovroff, M. C., Fraker, D. L., Norton, J. A. (1989). Cachectin Activity in the Serum of Cachectic, Tumor-Bearing Rats. Arch Surg 124: 94-99 [Abstract]
Meyer, J. D., Yurt, R. W., Duhaney, R., Hesse, D. G., Tracey, K. J., Fong, Y., Verma, M., Shires, G. T., Dineen, P., Lowry, S. F., Davis, J. M. (1988). Tumor Necrosis Factor--Enhanced Leukotriene B4 Generation and Chemotaxis in Human Neutrophils. Arch Surg 123: 1454-1458 [Abstract]
Reed, D., Moore, F. D. Jr (1988). Recombinant Human Tumor Necrosis Factor Increases Granulocyte Cell-Surface Complement Receptor Number. Arch Surg 123: 1333-1336 [Abstract]
Yuman Fong, , Lowry, S. F., Cerami, A. (1988). Cachectin/TNF: A Macrophage Protein That Induces Cachexia and Shock. JPEN J Parenter Enteral Nutr 12: 72S-77S [Abstract]
Hasselgren, P.-O., Pedersen, P., Sax, H. C., Warner, B. W., Fischer, J. E. (1988). Current Concepts of Protein Turnover and Amino Acid Transport in Liver and Skeletal Muscle During Sepsis. Arch Surg 123: 992-999 [Abstract]
Vlassara, H, Brownlee, M, Manogue, K., Dinarello, C., Pasagian, A (1988). Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548 [Abstract]
Warren, R. S., Starnes, H. F. Jr, Gabrilove, J. L., Oettgen, H. F., Brennan, M. F. (1987). The Acute Metabolic Effects of Tumor Necrosis Factor Administration in Humans. Arch Surg 122: 1396-1400 [Abstract]
Harris, R. L., Musher, D. M., Bloom, K., Gathe, J., Rice, L., Sugarman, B., Williams, T. W. Jr, Young, E. J. (1987). Manifestations of Sepsis. Arch Intern Med 147: 1895-1906 [Abstract]
Tchekmedyian, N. S., Tait, N., Moody, M., Aisner, J. (1987). High-Dose Megestrol Acetate: A Possible Treatment for Cachexia. JAMA 257: 1195-1198 [Abstract]
Tracey, K., Beutler, B, Lowry, S., Merryweather, J, Wolpe, S, Milsark, I., Hariri, R., Fahey, T. 3rd, Zentella, A, Albert, J., et, al. (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474 [Abstract]
Beutler, B, Krochin, N, Milsark, I., Luedke, C, Cerami, A (1986). Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977-980 [Abstract]
Fiers, W., Brouckaert, P., Devos, R., Fransen, L., Leroux-Roels, G., Remaut, E., Suffys, P., Tavernier, J., Van der Heyden, J., Van Roy, F. (1986). Lymphokines and Monokines in Anti-cancer Therapy. Cold Spring Harb Symp Quant Biol 51: 587-595 [Abstract]
Cerami, A., Beutler, B. (1986). Cachectin: The Dark Side of Tumor Necrosis Factor. Cold Spring Harb Symp Quant Biol 51: 625-629 [Abstract]
Lomedico, P.T., Kilian, P.L., Gubler, U., Stern, A.S., Chizzonite, R. (1986). Molecular Biology of Interleukin-1. Cold Spring Harb Symp Quant Biol 51: 631-639 [Abstract]
Sugarman, B., Aggarwal, B., Hass, P., Figari, I., Palladino, M. Jr, Shepard, H. (1985). Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945 [Abstract]
Old, L. (1985). Tumor necrosis factor (TNF). Science 230: 630-632
Torti, F., Dieckmann, B, Beutler, B, Cerami, A, Ringold, G. (1985). A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229: 867-869 [Abstract]
Beutler, B, Milsark, I., Cerami, A. (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871 [Abstract]